Literature DB >> 12447516

A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients.

Franck Lagneau1, Gilles D'honneur, Benoît Plaud, Jean Mantz, Thierry Gillart, Philippe Duvaldestin, Jean Marty, Nathalie Clyti, Jean-Louis Pourriat.   

Abstract

OBJECTIVES: To compare two levels of continuous cisatracurium-induced curarization in hypoxemic, ventilated patients. DESIGN AND
SETTING: An open-labeled, multicenter, prospective, randomized study. PATIENTS: Hundred two patients with a ratio between arterial oxygen tension and inspired oxygen tension (PaO(2)/FIO(2)) less than 200 despite optimization of sedation and ventilation were randomized into group 1 (n=52) with an end point of no response at orbicularis oculi to train-of-four (TOF) stimulation or group 2 (n=50) with an end point of two responses. MEASUREMENTS AND
RESULTS: The PaO(2)/FIO(2) and end-inspiratory plateau airway pressure (Pplat) were evaluated at baseline (before curarization) and at regular intervals once TOF end points had been attained for up to 2 h afterwards (T2 h). A decrease of 1 cmH(2)O or more of Pplat at T2 h compared to baseline was observed in 37% and 50% of the patients in groups 1 and 2, respectively (p=0.17). Time courses of PaO(2)/FIO(2) (mmHg) and Pplat (cmH(2)O) [mean (SD)] were equivalent in both groups, with a mild increase in PaO(2)/FIO(2) [p=0.0014; from 126 (33) to 141 (55) and from 134 (40) to 152 (52), respectively, in groups 1 and 2] and decrease in Pplat [p=0.016; from 29.1 (8.9) to 28.5 (8.8) and from 27.7 (7.5) to 26.6 (7.6)]. Median total durations of curarization were 28.9 h (3.1-219.7) in group 1 and 31.4 h (1.6-650.6) in group 2. Median cisatracurium infusion rates were 5.2 microg kg(-1) min(-1) (2.1-13.7) in group 1 and 3.6 microg kg(1) min(-1) (1.0-13.5) in group 2. The median delay to recovery from paralysis was shorter in group 2 (0.75 h vs 1.25 h; p=0.0008).
CONCLUSION: When a prolonged curarization is decided upon in an ICU patient, a blockade at 2/4 at TOF at orbicularis oculi has similar effects on respiratory parameters as a blockade at 0/4, allowing a decrease in total administered doses and a shortening of the recovery of muscle strength after cessation of infusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447516     DOI: 10.1007/s00134-002-1508-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

Review 1.  Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.

Authors:  Jeremy Bourenne; Sami Hraiech; Antoine Roch; Marc Gainnier; Laurent Papazian; Jean-Marie Forel
Journal:  Ann Transl Med       Date:  2017-07

2.  [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)].

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

3.  Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.

Authors:  Annelijn M Meeder; Marijke S van der Steen; Annemieke Rozendaal; Arthur R H van Zanten
Journal:  BMJ Case Rep       Date:  2016-10-03

4.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28

5.  Pharmacological interventions in acute respiratory distress syndrome.

Authors:  Antoine Roch; Sami Hraiech; Stéphanie Dizier; Laurent Papazian
Journal:  Ann Intensive Care       Date:  2013-07-03       Impact factor: 6.925

6.  Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.

Authors:  Pierre Bouju; Jean-Marc Tadié; Nicolas Barbarot; Julien Letheulle; Fabrice Uhel; Pierre Fillatre; Guillaume Grillet; Angélique Goepp; Yves Le Tulzo; Arnaud Gacouin
Journal:  Ann Intensive Care       Date:  2017-01-19       Impact factor: 6.925

Review 7.  Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Waleed Alhazzani; Mohamed Alshahrani; Roman Jaeschke; Jean Marie Forel; Laurent Papazian; Jonathan Sevransky; Maureen O Meade
Journal:  Crit Care       Date:  2013-03-11       Impact factor: 9.097

8.  A fresh look at paralytics in the critically ill: real promise and real concern.

Authors:  David Price; Nicholas J Kenyon; Nicholas Stollenwerk
Journal:  Ann Intensive Care       Date:  2012-10-12       Impact factor: 6.925

9.  A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.

Authors:  Alex Macario; John L Chow; Franklin Dexter
Journal:  BMC Med Inform Decis Mak       Date:  2006-03-15       Impact factor: 2.796

Review 10.  Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.

Authors:  Nehal Tarazan; Moayad Alshehri; Sameer Sharif; Zainab Al Duhailib; Morten Hylander Møller; Emilie Belley-Cote; Mohammed Alshahrani; John Centofanti; Lauralyn McIntyre; Bandar Baw; Maureen Meade; Waleed Alhazzani
Journal:  Intensive Care Med Exp       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.